Cytophage Technologies (TSXV:CYTO) Price-to-Owner-Earnings : (As of Jun. 10, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Price-to-Owner-Earnings?

As of today (2024-06-10), Cytophage Technologies's share price is C$0.415. Cytophage Technologies does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.

The historical rank and industry rank for Cytophage Technologies's Price-to-Owner-Earnings or its related term are showing as below:

TSXV:CYTO's Price-to-Owner-Earnings is not ranked ^*
in the Biotechnology industry.
Industry Median: 34.2
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-10), Cytophage Technologies's share price is C$0.415. Cytophage Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.05. Therefore, Cytophage Technologies's PE Ratio for today is At Loss.

As of today (2024-06-10), Cytophage Technologies's share price is C$0.415. Cytophage Technologies's EPS without NRI for the trailing twelve months (TTM) ended in was C$-0.05. Therefore, Cytophage Technologies's PE Ratio without NRI for today is At Loss.

During the past 3 years, Cytophage Technologies's highest PE Ratio without NRI was 12.00. The lowest was 0.00. And the median was 0.00.

Cytophage Technologies Price-to-Owner-Earnings Historical Data

The historical data trend for Cytophage Technologies's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Price-to-Owner-Earnings Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Price-to-Owner-Earnings

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Price-to-Owner-Earnings	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Cytophage Technologies's Price-to-Owner-Earnings

For the Biotechnology subindustry, Cytophage Technologies's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cytophage Technologies's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytophage Technologies's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Cytophage Technologies's Price-to-Owner-Earnings falls into.

Cytophage Technologies Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Cytophage Technologies's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	0.415	/	0.00
	=

Cytophage Technologies (TSXV:CYTO) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

Cytophage Technologies Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Price-to-Owner-Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.